Sepsis is a systemic, deleterious host response to infection leading to acute organ dysfunction secondary to documented or suspected infection and septic shock i.e. sepsis plus hypotension not reversed with fluid resuscitation. Severe sepsis is a major healthcare problem with an extremely high mortality rate of 30-60% and it is one of the most common reasons for critically ill patients to be admitted to an intensive care unit (ICU). Excessive inflammation and coagulation and suppression of fibrinolysis are the hallmarks of Sepsis. Our medical concern is to manage sepsis and to prevent multi organ failure (MOF). Making an early, accurate diagnosis of septic shock is the key to increasing survival rates. With no specific, effective anti-sepsis therapies available, management focuses on haemodynamic stabilization and rapid resuscitation, early source control, adequate and appropriate antibiotics, organ support and modulation of the septic responses are the cornerstones of treatment.
Introduction:
Sepsis is defined as a severe infection with some degree of associated organ dysfunction (i.e. presence of SIRS in the setting of infection) 1 and affects a large proportion of the critically ill population. In recent years, it has become clear that perhaps the most important as-pect of the management of patients with sepsis is early recogni-tion so that administration of antibiotics, source control measures and effective resuscitation strategies can be started as soon as possible after onset. Early management with adequate antimicro-bials and rapid resuscitation to restore and stabilize hemodynam-ic status has been shown to be associated with improved out-comes. [1] [2] [3] [4] [5] However, diagnosis of sepsis is not always easy, especially in critically ill patients with other conditions and signs and symptoms that can mimic severe infection . [4] [5] [6] The morbidity and mortality of sepsis in low-and middleincome countries (LMICs) are believed to be disproportionately high, due to environmental degradation, widespread malnutrition, and higher rates of bacterial, parasitic, fungal and HIV infection. [7] [8] [9] [10] In an effort to reduce the risk of death from sepsis, the Surviving Sepsis Campaign (SSC) was initiated in 2002 from the collaboration of the European Society of Intensive Care Medicine (ESICM), the International Sepsis Forum (ISF), and the Society of Critical Care Medicine (SSCM). In 2004, the SSC produced the ''Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock,'' one of the most recognized consensus statements regarding the treatment of sepsis (most recently updated in 2012). 1 This review will discuss the epidemiology, pathophysiology, and diagnostic and therapeutic approach to patients with sepsis, severe sepsis, and septic shock in acute care settings.
Epidemiology:
Despite the documented impact of sepsis in developed countries, literature on its incidence, prevalence, and mortality in developing countries is sparse. [8] [9] [10] [11] The global burden of sepsis lies in LMICs. As a surrogate marker for sepsis, over 90% of worldwide deaths due to pneumonia, meningitis, and other infections occur in less developed nations (specific etiology usually gram positive or gram negative septicemia and rarely fungi, viruses). Globally, an estimated 70% of the 9 million annual neonatal and infant deaths are attributable to sepsis, and more than half of these occur in Asia and Sub-Saharan Africa. 9, 12-13
Pathophysiology:
In sepsis multiple organ dysfunction syndrome(MODS)-[Ischemic encephalopathy, diminished myocardial contractility, ARDS, ATN, DIC, Hemorrhagic enteropathy, Cortical cell lipid depletion in adrenal gland etc.] appears to result from a cascade of organism-related factors, circulating immune or inflammatory mediators, diffuse endothelial cell injury, disturbed hemostasis or tissue/organ hypoperfusion, and microcirculatory abnormalities (microaggregation of microthrombi). In patients with severe sepsis, derangements of inflammation and coagulation are tightly linked. Free radicals, superoxide's, proteolytic enzymes are also directly involved the pathophysiology and occasionally impaired the cellular or the organ function. [1] [2] [3] 
dysuria in occult urinary tract infections).
The physical examination should be used to identify possible foci of source control. A critical action at this point is the measurement, documentation, and evaluation of vital signs, including temperature, blood pressure (BP), heart rate (HR), respiratory rate (RR) and oxygen saturation (if below 90% then supplemental Oxygen should be immediately applied). Repeated recording of these parameters will be used to evaluate clinical improvement or deterioration and trigger specific interventions. 1, [14] [15] Consistently analyzing the vital signs for the presence of SIRS criteria in any possible patient with sepsis will aid in the early recognition of critical illness. Importantly, vital sign derangements may be absent early in elderly patients. Specific physical exam findings that are predictive of sources of infection include indwelling devices (e.g., intravascular or urinary catheters), rales, abdominal tenderness, and evidence of CNS infection. A cardiovascular and volume status assessment, including auscultation, mucous membranes, skin colour and turgor, peripheral pulses, capillary refill and edema should be undertaken at this stage as well. 1, 14-15
Investigations:
Initial laboratory and radiographic testing is aimed at locating a source of infection and identifying evidence of organ dysfunction.
Common laboratory studies include:
1-3, 14-17
• Complete blood count (white blood cell count including a differential of subtypes and measure of bands, haemoglobin and haematocrit, platelets),
• Chemistries(electrolytes, bicarbonate, creatinine, glucose),
• Prothrombin time (PT)
• Liver transaminases, bilirubin,
• Arterial or venous blood gas analysis with the inclusion of a serum lactate level,
• Urinalyses are of high-yield, particularly in patients older than 65
• Chest radiography is to identify sources of pulmonary infection and causes of respiratory distress,
• Cultures as clinically appropriate before antimicrobial therapy with no significant delay (> 45 minutes) in the start of antimicrobials. At least 2 sets of blood cultures (both aerobic and anaerobic bottles) be obtained before antimicrobial therapy
• Urine, pus, ascetic fluid, pleural fluid, may be sent for culture where appropriate
Treatment and management
General management: The key principles of management of sepsis include early recognition, titrated fluid resuscitation, adequate source control, obtain blood cultures prior to administration of antibiotics, administer broad spectrum antibiotics, and organ support. Prompt recognition of the septic patient is critical, and early In patients with elevated lactate levels targeting resuscitation to normalize lactate. 1 In such instances, a goal-directed approach to therapy is recommended by consensus guidelines with measurable endpoints at the 3-and 6-h marks. 1 Values significantly below this may be suggestive of hypovolaemia and the potential need for additional fluid resuscitation. This intervention alone has been shown to reduce mortality. [21] [22] In ProCESS trial; aggressive fluid resuscitation (an average of 4.4 L in the first 6 h in this study) causes reduce mortality. 20 Fluid selection: Crystalloids as the initial fluid of choice in the resuscitation of severe sepsis and septic shock. Albumin is needed in the fluid resuscitation of severe sepsis and septic shock when patients require substantial amounts of crystalloids. Initial fluid challenge or goal in patients with sepsis-induced tissue hypoperfusion is to achieve a minimum of 30 mL/kg of crystalloids. 1, [21] [22] Vasopressors: Vasopressor therapy initially to target a mean arterial pressure (MAP) of 65 mm Hg .Norepinephrine as the first choice vasopressor. Epinephrine is added when an additional agent is needed to maintain adequate blood pressure. Vasopressin 0.03 units/minute can be added to norepinephrine (NE) with intent of either raising MAP in refractory hypotension and have beneficial hemodynamic and renal function effects 6 .Dopamine is an alternative vasopressor to norepinephrine only in highly selected patients. Lowdose dopamine should not be used for renal protection 1
Table-IV

Surviving Sepsis Campaign Bundles 1
To be completed within 3 hours: 1) Measure lactate level 2) Obtain blood cultures prior to administration of antibiotics 3) Administer broad spectrum antibiotics 4) Administer 30 mL/kg crystalloid for hypotension or lactate e" 4mmol/Lto be completed within 6 hours: In a recent, multicenter trial comparing norepinephrine and dopamine, both were equally efficacious at reversing hypotension and there was no significant difference in mortality, though there were more arrhythmias in the dopamine group. 1
Antimicrobial Therapy
Administration of effective intravenous antimicrobials within the first hour of recognition of septic shock and severe sepsis is the norm. Initial empiric anti-infective therapy should be one or more drugs that have activity against all likely pathogens (bacterial and/or fungal or viral) and that penetrate inadequate concentrations into tissues. Antimicrobial regimen should be reassessed daily. Before starting antimicrobials blood /urine culture should be sent. Combination empirical therapy for neutropenic patients with severe sepsis may be needed. Empiric combination therapy should not be administered for more than 3-5 days (till culture report comes) .Duration of therapy typically 7-10 days; longer courses may be appropriate in patients who have a slow clinical response. Antiviral therapy may be initiated as early as possible in patients with severe sepsis or septic shock of viral origin. 1 The choice of empirical antibacterial therapy varies significantly based on patient characteristics. Important considerations include the most likely source(s) of infection, recent antibiotics (last 3 months), recent health care exposure (e.g., hospitalization), underlying chronic disease, local pathogens and drug resistance. Patients with recent antibiotic exposure have an elevated incidence of high-risk infections such as methicillinresistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, whereas those with recent healthcare exposure have increased likelihood of being colonized with extended spectrum beta-lactamase (ESBL)-producing bacteria. 1
Source Control
A specific anatomical diagnosis of infection requiring consideration for emergent of source control. If intravascular access devices or indwelling catheter are a possible source of severe sepsis or septic shock, they should be removed promptly. When infected peripancreatic necrosis is identified, definitive intervention is best delayed until adequate demarcation of viable and nonviable tissues has occurred. Selective oral decontamination and selective digestive decontamination should be introduced to reduce the incidence of ventilator-associated pneumonia. 1, 23 Corticosteroids Intravenous hydrocortisone is not encouraged to treat adult septic shock patients if adequate fluid resuscitation and vasopressor therapy are able to restore hemodynamic stability. Corticosteroids were not shown to be beneficial in SS/SS and in fact, potentially worsened outcomes. However, a later study by Annane et al demonstrated that patients with vasopressorunresponsive septic shock when treated with low-dose hydrocortisone and fludrocortisones causes shock reversal and reduces mortality. However a follow-up large multicenter trial (CORTICUS), showed that septic shock patients who responded to vasopressors, did not show a survival benefit with low-dose steroids. 1, [24] [25] [26] [27] [28] Blood Product Administration Once tissue hypoperfusion has resolved, target hemoglobin is 7.0 -9.0 g/dL in adults. In patients with severe sepsis, administer platelets when counts are <10,000/mm3 in the absence of apparent bleeding. Prophylactic platelet transfusion is advised when counts are < 20,000/mm3 if there is a significant risk of bleeding. Platelet counts (e"50,000/mm3) are advised for active bleeding, surgery, or invasive procedures . 1 
Glucose Control
Insulin should be started when 2 consecutive blood glucose levels are>10mmol/L (>180mg/dl) in ICU patient with severe sepsis. Blood glucose values should be monitored every 1-2 hrs until glucose values and insulin infusion rates are stable and then every 4 hrs thereafter. 1 In resource-limited settings, check blood glucose levels in all patients. In the presence of mild hyperglycaemia, one should be careful about precipitating hypoglycaemia by insulin which may be more harmful. 2 
Renal Replacement Therapy
Renal replacement therapies and intermittent hemodialysis may be required in patients with Bicarbonate Therapy. Sodium bicarbonate is not recommended in patients with hypoperfusion-induced lactic acidemia when pH is ≥7. 1.
Deep Vein Thrombosis Prophylaxis
Patients with severe sepsis should receive prophylaxis against venous thromboembolism (VTE) with daily subcutaneous LMWH. Combination of pharmacologic therapy and intermittent pneumatic compression devices may be needed. 1 Stress Ulcer Prophylaxis H2 blocker or proton pump inhibitor should be given to patients with severe sepsis/septic shock with bleeding risk. 1 Mechanical Ventilation of Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
Target tidal volume of 6 mL/kg body weight is recommended in patients with sepsis-induced ARDS. Positive end-expiratory pressure (PEEP) should be applied to avoid alveolar collapse at end expiration. Mechanically ventilated sepsis patients should be maintained with the head of the bed elevated to 30-45 degrees to limit aspiration and to prevent ventilatorassociated pneumonia. 1, 29 The inflammatory response to sepsis can cause lung injury and the development of ARDS. In a landmark multicenter randomized trial of lung-injured patients, those who underwent mechanical ventilation had a 9% absolute reduction in mortality. [29] [30] Immunoglobulins and Selenium Intravenous immunoglobulin and selenium is not recommended in adult patients with severe sepsis or septic shock. .1 Sedation, Analgesia, and Neuromuscular blockade in Sepsis Continuous or intermittent sedation should be minimized in mechanically ventilated sepsis patients. Neuromuscular blocking agents (NMBAs) should be avoided in the septic patient without ARDS .1
Nutrition
Initiate oral or enteral feedings rather than either complete fasting or only intravenous glucose within the first 48 hours. Avoid full caloric feeding in the first week rather low dose feeding (up to 500 calories per day), gradually increasing as tolerated is recommended. 1 
Supporting evidence
Administration of human recombinant activated protein C is no longer recommended. The drug failed to show a survival benefit for patients with severe sepsis and septic shock . 1
Conclusion:
Severe sepsis is a major healthcare problem with an extremely high mortality rate of 30-60%. Consensus guidelines exist with specific recommendations for a bundled approach to the treatment of septic patients, and in particular, those with SS/SS. Our medical concern is to manage sepsis and to prevent MOF. Early sepsis recognition (e.g. serum lactate measurement), optimization of oxygen delivery (e.g. fluid resuscitation and vasopressors) and infection treatment (e.g. appropriate antibiotics and infection control, preceded by blood cultures) may result in a significant reduction in mortality and morbidity.
